Example: dental hygienist

JP Morgan Presentation

Zeposia CD New Product Portfolio To Deliver $10B - $13B of Risk Adjusted Revenue in 2025 * Other includes: Abecma, Onureg, Inrebic, and rela+nivo FDC 12 ** Non-risk adjusted revenue potential, subject to positive registrational trials and health authority approval.

Tags:

  Zeposia

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries